Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Rare disease

Acute myeloid leukaemia refractory

  • 8 clinical trials
Quick filters

8 Clinical trials

Acute myeloid leukaemia refractory+2

Recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Aop Orphan Pharmaceuticals GmbH

Acute lymphocytic leukaemia recurrent+5

Recruiting
InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD3632
  • Sponsor:AstraZeneca AB

T-cell type acute leukaemia+2

Recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Gyala Therapeutics S.L.

Acute myeloid leukaemia refractory+1

Recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Stelexis Biosciences Inc.

Acute myeloid leukaemia refractory+1

Recruiting
InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:ELTANEXOR
  • Sponsor:Azienda Ospedaliero Universitaria Delle Marche

Acute myeloid leukaemia refractory+1

Not yet recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cctx-001
  • Sponsor:CanCell Therapeutics
See all trials →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.